C reactive protein and serum amyloid A predict risk after myocardial infarction

In the CARE trial of 782 patients with a recent myocardial infarction, patients with serum concentrations of C-reactive protein or amyloid A in the highest quintile had a significantly greater risk for a recurrent fatal or nonfatal cardiac event compared to those with values in the lowest quintile.